(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
最近の投稿
- 1
Asia's Noteworthy Destinations: A Voyager's Aide - 2Step by step instructions to Show Children the Significance of Appropriate Handshaking
- 3Want to be better about saving money in 2026? Try these money-saving tips for having a ‘low-buy’ January and beyond
- 4Lawsuit claims ChatGPT exacerbated man's delusions leading to murder-suicide
- 5Fetterman says he's back home after a fall put the Pennsylvania senator in the hospital
- Overseeing Individual budgets Successfully
- Vote In favor of Your Favored Sort Of Dress
- Best Internet based Course for Learning Another Dialect: Which Stage Do You Like?
- The next frontier in space is closer than you think – welcome to the world of very low Earth orbit satellites
- Regeneron's experimental therapy combo effective in untreated cancer patients
- Vote in favor of the handheld vacuum that you love for its strong attractions!
- What loving-kindness meditation is and how to practice it in the new year
- 4 Famous Attractions at Disneyland
- Comet C/2025 K1 (ATLAS) breaks apart in incredible telescope photos
